Emerald ash borer confirmed in Moncton, New Brunswick
OTTAWA, Aug. 23, 2019 /CNW/ - The Canadian Food Inspection Agency (CFIA) has confirmed the presence of emerald ash borer in Moncton, New Brunswick. This detection is outside of currently regulated areas for emerald ash borer in Canada, and is the third detection of EAB in the province.
CFIA and its partners are conducting additional surveys to determine whether the pest has become established in the area, and if so, the extent of the spread.
Effective immediately, the movement of all ash material (such as logs, branches, and woodchips) and all species of firewood from the affected site is restricted. The property owners in the affected area have been notified of these restrictions.
Although the emerald ash borer poses no threat to human health, it is highly destructive to ash trees. It has already killed millions of ash trees in Canada and the United States, and poses a major economic and environmental threat to urban and forested areas of North America.
CFIA continues to work with federal, provincial, municipal and First Nations partners and organizations to slow the spread of this pest.
Quick facts
Moving untreated firewood is a common way for invasive insects and diseases to spread.
The emerald ash borer is native to China and eastern Asia. Its presence in Canada was first confirmed in 2002. It has since been found in parts of five provinces.
CFIA regulates this pest to protect Canada's forests, municipal trees and nurseries.
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....